PL308473A1 - Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids - Google Patents

Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids

Info

Publication number
PL308473A1
PL308473A1 PL93308473A PL30847393A PL308473A1 PL 308473 A1 PL308473 A1 PL 308473A1 PL 93308473 A PL93308473 A PL 93308473A PL 30847393 A PL30847393 A PL 30847393A PL 308473 A1 PL308473 A1 PL 308473A1
Authority
PL
Poland
Prior art keywords
enabntiomeric
dihydoxychroman
bezoic
cis
acids
Prior art date
Application number
PL93308473A
Inventor
Charles W Murtiashaw Iii
Brian C Vanderplas
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PL308473A1 publication Critical patent/PL308473A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PL93308473A 1992-10-21 1993-06-30 Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids PL308473A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96433692A 1992-10-21 1992-10-21
PCT/US1993/006061 WO1994008986A1 (en) 1992-10-21 1993-06-30 Enantiomeric cis-3-(4,6-dihydroxychroman-3-yl-methyl)benzoic acids

Publications (1)

Publication Number Publication Date
PL308473A1 true PL308473A1 (en) 1995-08-07

Family

ID=25508434

Family Applications (1)

Application Number Title Priority Date Filing Date
PL93308473A PL308473A1 (en) 1992-10-21 1993-06-30 Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids

Country Status (16)

Country Link
EP (1) EP0665839A1 (en)
JP (1) JPH07507811A (en)
KR (1) KR950704291A (en)
CN (1) CN1090577A (en)
AU (1) AU4650493A (en)
CA (1) CA2146005A1 (en)
CZ (1) CZ100895A3 (en)
FI (1) FI934624A (en)
HU (1) HUT65128A (en)
IL (1) IL107293A0 (en)
MX (1) MX9306526A (en)
MY (1) MY131378A (en)
NO (1) NO951507D0 (en)
PL (1) PL308473A1 (en)
WO (1) WO1994008986A1 (en)
ZA (1) ZA937737B (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SK31399A3 (en) * 1996-09-16 2000-05-16 Pfizer Processes and intermediates for preparing substituted chromanol derivatives
IL149256A0 (en) 1999-10-27 2002-11-10 Nobex Corp Resolution of intermediates in the synthesis of substantially pure bicalutamide
MY128450A (en) 2000-05-24 2007-02-28 Upjohn Co 1-(pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
US6479692B1 (en) 2001-05-02 2002-11-12 Nobex Corporation Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
US7601855B2 (en) 2004-09-21 2009-10-13 Novogen Research Pty Ltd Substituted chroman derivatives, medicaments and use in therapy
US8080675B2 (en) 2004-09-21 2011-12-20 Marshall Edwards, Inc. Chroman derivatives, medicaments and use in therapy
EP2635121B1 (en) 2010-11-01 2020-01-08 MEI Pharma, Inc. Isoflavonoid compounds and methods for the treatment of cancer
HUE054998T2 (en) 2015-02-02 2021-10-28 Mei Pharma Inc Combination therapies for use in the treatment of breast cancer

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5059609A (en) * 1987-10-19 1991-10-22 Pfizer Inc. Substituted tetralins, chromans and related compounds in the treatment of asthma, arthritis and related diseases

Also Published As

Publication number Publication date
MX9306526A (en) 1994-04-29
WO1994008986A1 (en) 1994-04-28
CN1090577A (en) 1994-08-10
HUT65128A (en) 1994-04-28
FI934624A (en) 1994-04-22
CA2146005A1 (en) 1994-04-28
AU4650493A (en) 1994-05-09
NO951507L (en) 1995-04-20
EP0665839A1 (en) 1995-08-09
MY131378A (en) 2007-08-30
ZA937737B (en) 1995-04-19
HU9302973D0 (en) 1993-12-28
NO951507D0 (en) 1995-04-20
CZ100895A3 (en) 1995-10-18
IL107293A0 (en) 1994-01-25
JPH07507811A (en) 1995-08-31
KR950704291A (en) 1995-11-17
FI934624A0 (en) 1993-10-20

Similar Documents

Publication Publication Date Title
IL102813A0 (en) Imidazolyl-alkenoic acids
GB9204480D0 (en) Catches
GB9325558D0 (en) Percaboxylic acids
EP0577348A3 (en) Amidoamines
EP0563238A4 (en) Imidazolyl-alkenoic acids
PL308473A1 (en) Enabntiomeric cis-3-(4,6-dihydoxychroman-3-yl methyl)bezoic acids
ZA919058B (en) Sulfimidoperoxycarboxylic acids
GB9221883D0 (en) Novel formulation
ZA946158B (en) Methyl 3-methoxy-2-phenyl-acrylates
ZA933848B (en) Pyridyl-1,2,5-oxadiazolecarboxamide-2-oxides
GB9214373D0 (en) Newadjustable "photo-back"
GB9323975D0 (en) An implement
GB9309154D0 (en) An implement
ZA933757B (en) Cyclopentane-and-pentene-beta-amino acids
GB9108865D0 (en) Sprayer
GB9309158D0 (en) An implement
GB9210532D0 (en) Car-anti-theft-system 1
GB9220394D0 (en) Datacab 2
ZW9390A1 (en) Imidazolyl-alkenoic acids
IE900338L (en) Heteroaryl-1-alkyl-pyrrole-2-carboxylic acids
IE900337L (en) Heteroaryl-1-alkyl-pyrrole-2-carboxylic acids
IE900361L (en) Saccharoascorbic acids
GB9201915D0 (en) Formulation
GB9202110D0 (en) Formulation
ZA928061B (en) Lipomimetic formulation